article thumbnail

HHS: Medicare incentives, penalties for hospitals could help stem drug shortages

Fierce Healthcare

The program, and its complementary effort targeting manufacturers, would require new authorities from Congress.

Hospitals 115
article thumbnail

MA enrollees have fewer hospitalizations, Harvard study finds

Fierce Healthcare

Another white paper released by Inovalon and Harvard Medical School highlights the benefits Medicare Advantage enrollees enjoy over traditional Medicare counterparts.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Long-term care hospitals can't afford to treat their sickest Medicare patients, AHA says

Fierce Healthcare

Traditional Medicare’s bar for reimbursing long-term care hospitals (LTCH) for severely ill, “high-cost outlier” patients has spiked under current payment policies. |

Hospitals 112
article thumbnail

PharmD Live Releases White Paper on Pharmacist-Led Virtual Care to Maximize Shared Savings for Payviders

PharmD Live

WASHINGTON, February 18, 2025 PharmD Live , an innovative pharmacist-led virtual care solution powered by AI-driven algorithms, announces the release of its recent white paper, Maximizing Shared Savings for Payviders: ACOs, IDNs, At-Risk Provider Groups and Clinics. Download the white paper here.

article thumbnail

Hospital Universitario and Josep Carreras develop cell therapy for leukaemia

Pharmaceutical Technology

Spain’s Hospital Universitario 12 de Octubre researchers, along with the Josep Carreras Leukaemia Research Institute, have developed a new cell therapy based on STAb cells to treat a type of leukaemia. The post Hospital Universitario and Josep Carreras develop cell therapy for leukaemia appeared first on Pharmaceutical Technology.

Hospitals 110
article thumbnail

Healthware and Italian cancer institute partner on digital health drive

pharmaphorum

The overall aim of the alliance – which will see Healthware work alongside the NCI’s Pascale Hospital – is to develop digital health tools that will deliver “more precise and accessible treatments to patients”, said the partners in a statement.

article thumbnail

Kite and Daiichi Sankyo update cell therapy licensing agreement

Pharmaceutical Technology

In December last year, the first centre in Japan received authorisation to administer the therapy, while six regional hospitals are currently approved to offer this treatment. The delivery of the product is anticipated to begin early next year.